US Bancorp’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$49.9K Sell
2,087
-183
-8% -$4.37K ﹤0.01% 2788
2025
Q1
$56.4K Buy
2,270
+537
+31% +$13.3K ﹤0.01% 2685
2024
Q4
$32.7K Sell
1,733
-234
-12% -$4.41K ﹤0.01% 2935
2024
Q3
$29.6K Sell
1,967
-8,442
-81% -$127K ﹤0.01% 2977
2024
Q2
$298K Sell
10,409
-1,333
-11% -$38.1K ﹤0.01% 1791
2024
Q1
$343K Sell
11,742
-916
-7% -$26.8K ﹤0.01% 1727
2023
Q4
$427K Buy
12,658
+1,605
+15% +$54.2K ﹤0.01% 1601
2023
Q3
$339K Buy
11,053
+664
+6% +$20.4K ﹤0.01% 1567
2023
Q2
$416K Sell
10,389
-933
-8% -$37.4K ﹤0.01% 1479
2023
Q1
$462K Sell
11,322
-658
-5% -$26.9K ﹤0.01% 1445
2022
Q4
$463K Sell
11,980
-1,015
-8% -$39.2K ﹤0.01% 1436
2022
Q3
$692K Sell
12,995
-1,244
-9% -$66.2K ﹤0.01% 1231
2022
Q2
$830K Sell
14,239
-2,608
-15% -$152K ﹤0.01% 1175
2022
Q1
$1.29M Buy
16,847
+614
+4% +$46.9K ﹤0.01% 1067
2021
Q4
$977K Buy
16,233
+720
+5% +$43.3K ﹤0.01% 1211
2021
Q3
$869K Buy
15,513
+1,754
+13% +$98.3K ﹤0.01% 1257
2021
Q2
$834K Buy
13,759
+549
+4% +$33.3K ﹤0.01% 1291
2021
Q1
$926K Sell
13,210
-247
-2% -$17.3K ﹤0.01% 1174
2020
Q4
$804K Buy
13,457
+1,124
+9% +$67.2K ﹤0.01% 1199
2020
Q3
$741K Buy
12,333
+2,727
+28% +$164K ﹤0.01% 1119
2020
Q2
$504K Buy
9,606
+3,902
+68% +$205K ﹤0.01% 1287
2020
Q1
$191K Sell
5,704
-52
-0.9% -$1.74K ﹤0.01% 1667
2019
Q4
$261K Buy
5,756
+3,557
+162% +$161K ﹤0.01% 1699
2019
Q3
$84K Sell
2,199
-2,174
-50% -$83K ﹤0.01% 2246
2019
Q2
$190K Buy
4,373
+375
+9% +$16.3K ﹤0.01% 1856
2019
Q1
$152K Buy
3,998
+117
+3% +$4.45K ﹤0.01% 1958
2018
Q4
$167K Buy
3,881
+435
+13% +$18.7K ﹤0.01% 1854
2018
Q3
$169K Sell
3,446
-2,592
-43% -$127K ﹤0.01% 1953
2018
Q2
$194K Buy
6,038
+1,746
+41% +$56.1K ﹤0.01% 1879
2018
Q1
$134K Buy
4,292
+1,501
+54% +$46.9K ﹤0.01% 2088
2017
Q4
$127K Buy
2,791
+103
+4% +$4.69K ﹤0.01% 2137
2017
Q3
$101K Buy
2,688
+237
+10% +$8.91K ﹤0.01% 2235
2017
Q2
$117K Sell
2,451
-6,538
-73% -$312K ﹤0.01% 2111
2017
Q1
$410K Buy
8,989
+3,015
+50% +$138K ﹤0.01% 1472
2016
Q4
$193K Sell
5,974
-1,246
-17% -$40.3K ﹤0.01% 1802
2016
Q3
$247K Buy
7,220
+2,210
+44% +$75.6K ﹤0.01% 1670
2016
Q2
$169K Buy
5,010
+394
+9% +$13.3K ﹤0.01% 1770
2016
Q1
$244K Buy
4,616
+1,139
+33% +$60.2K ﹤0.01% 1610
2015
Q4
$267K Buy
3,477
+1,862
+115% +$143K ﹤0.01% 1569
2015
Q3
$66K Sell
1,615
-274
-15% -$11.2K ﹤0.01% 2320
2015
Q2
$133K Sell
1,889
-156
-8% -$11K ﹤0.01% 1975
2015
Q1
$181K Sell
2,045
-1,842
-47% -$163K ﹤0.01% 1832
2014
Q4
$345K Buy
3,887
+2,425
+166% +$215K ﹤0.01% 1527
2014
Q3
$142K Buy
1,462
+727
+99% +$70.6K ﹤0.01% 1926
2014
Q2
$68K Buy
735
+325
+79% +$30.1K ﹤0.01% 2342
2014
Q1
$29K Sell
410
-1,940
-83% -$137K ﹤0.01% 2695
2013
Q4
$135K Sell
2,350
-962
-29% -$55.3K ﹤0.01% 1936
2013
Q3
$160K Buy
3,312
+1,262
+62% +$61K ﹤0.01% 1796
2013
Q2
$59K Buy
+2,050
New +$59K ﹤0.01% 2253